Protein tyrosine phosphatase genes downregulated in melanoma

Journal of Investigative Dermatology

Volumn 117, Issue 5, 2001, Pages 1255-1260

  McArdle, Linda ^a   Rafferty, Mairin ^a   Mælandsmo, Gunhild M ^b   Bergin, Orla ^a   Farr, Christine J ^c   Dervan, Peter A ^d   O’loughlin, Sean ^d   Herlyn, Meenhard ^e   Easty, David J ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^e WISTAR INSTITUTE   (United States)

Author keywords

Melanocyte; Metastasis; PTP ; PTP

Indexed keywords

PROTEIN TYROSINE PHOSPHATASE;

ANIMAL CELL; ARTICLE; CONTACT INHIBITION; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME ACTIVITY; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MELANOCYTE; MELANOMA; MELANOMA CELL; MOLECULAR CLONING; NONHUMAN; NORTHERN BLOTTING; PIGMENT CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR BIOPSY; TUMOR SUPPRESSOR GENE;

EID: 0035723399     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0022-202X.2001.01534.x     Document Type: Article

References (35)

1. Molecular genetics of human malignant melanoma
2. Molecular classification of cutaneous malignant melanoma by gene expression profiling
3. Dynamic interaction of PTPmu with multiple cadherins in vivo
4. Effect of protein tyrosine phosphatase 1B expression on transformation by the human neu oncogene
5. Regulation of growth factor-induced signaling by protein-tyrosine-phosphatases
6. Malignant melanoma: Modern black plague and genetic black box
7. Protein tyrosine kinases in malignant melanoma
8. Novel and known protein tyrosine kinases and their abnormal expression in human melanoma
9. Protein B61 as a new growth factor: Expression of B61 and up-regulation of its receptor epithelial cell kinase during melanoma progression
10. Abnormal protein tyrosine kinase gene expression during melanoma progression and metastasis
11. Levels of nm23 messenger RNA in metastatic malignant melanomas: Inverse correlation to disease progression
12. Association of human protein-tyrosine phosphatase kappa with members of the armadillo family
13. A receptor-type protein tyrosine phosphatase PTP zeta is expressed in human cutaneous melanomas
14. Intertumoral heterogeneity of receptor-tyrosine kinase expression in human melanoma cell lines with different metastatic capabilities
15. Growth factors, receptor kinases, and protein tyrosine phosphatases in normal and malignant melanocytes
16. Cultivation of normal human epidermal melanocytes
17. The Croonian lecture 1997. The phosphorylation of proteins on tyrosine: Its role in cell growth and disease
18. Aberrant melanogenesis and melanocytic tumour development in transgenic mice that carry a metallothionein/ret fusion gene
19. Variant sublines of early-stage human melanomas selected for tumorigenicity in nude mice express a multicytokine-resistant phenotype
20. Protein tyrosine phosphatase PTP1B suppresses p210 bcr-abl-induced transformation of rat-1 fibroblasts and promotes differentiation of K562 cells
21. Requirement for focal adhesion kinase in tumor cell adhesion
22. Recent advances in melanoma staging and therapy
23. Protein tyrosine phosphatases in signal transduction
24. Expression of protein-tyrosine phosphatases in the major insulin target tissues
25. c-met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype
26. Protein kinases in normal and transformed melanocytes
27. Protein-tyrosine phosphatases
28. The coordinated action of protein tyrosine phosphatases and kinases in cell signaling
29. Receptor protein tyrosine kinases and their signal transduction pathways
30. Receptor tyrosine kinase Xmrk mediates proliferation in Xiphophorus melanoma cells
31. Increasing epidermal growth factor receptor expression in human melanocytic tumor progression
32. Transforming growth factor-beta1 inhibits human keratinocyte proliferation by upregulation of a receptor-type tyrosine phosphatase R-PTP-kappa gene expression
33. Suppression of v-fms-induced transformation by overexpression of a truncated T-cell protein tyrosine phosphatase
34. Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene
35. Cytogenetical assignment and physical mapping of the human R-PTP-kappa gene (RPTPK) to the putative tumor suppressor gene region 6q22.2-q22.3